|
Recent Developments |
|
10-MAY-17
Marksans Pharma's Goa plant has been approved by UK Medicines and Healthcare products Regulatory Agency (UK MHRA). The UK's healthcare regulator inspected the company's Goa plant from February 14, 2017 to February 17, 2017.
10-APR-17
Marksans Pharma manufacturing facility at Verna, Goa has been audited by the United States Food and Drug Administration (USFDA) from April 3 to 7, 2017.
18-OCT-16
Marksans Pharma announced that USFDA ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2016(12) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | | Net sales | 3645.20 | 4055.94 | 3149.45 | | Other Income | 0.00 | 0.00 | 0.00 | | Total Income | 3645.20 | 4055.94 | 3149.45 | | Cost of goods sold | 2586.28 | 2898.53 | 2311.28 | | OPBDIT | 1058.92 | 1157.41 | 838.17 | | PAT | 714.86 | 671.09 | 555.58 | | Gross Block | - | - | - | | Equity capital | 409.31 | 409.31 | 385.31 | | EPS (Rs.) | - | 1.64 | 1.44 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 12.26 - 43.90 | 2.50 - 18.33 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 29.0 | 28.5 | 26.6 | | Net margin (% of OI) | 19.6 | 16.5 | 17.6 |
|
|
Detailed Financials
|
|
|
|
|
